Skip to main content
Clinical Trials/ISRCTN40292537
ISRCTN40292537
Completed
未知

Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II): an observational study using linked Scottish national data

Academic and Clinical Centre Office for Research and Development (ACCORD) (UK)0 sites5,400,000 target enrollmentNovember 17, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
COVID-19 (SARS-CoV-2 infection)
Sponsor
Academic and Clinical Centre Office for Research and Development (ACCORD) (UK)
Enrollment
5400000
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/32565483/ protocol published at: 2021 Preprint results in http://dx.doi.org/10.2139/ssrn.3789264 non-peer-reviewed results (added 23/03/2021) 2022 Results article in https://doi.org/10.1016/S0140-6736(21)00677-2 (added 26/05/2022)

Registry
who.int
Start Date
November 17, 2020
End Date
September 30, 2021
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Academic and Clinical Centre Office for Research and Development (ACCORD) (UK)

Eligibility Criteria

Inclusion Criteria

  • All (anonymised) patient data will be collected

Exclusion Criteria

  • Does not meet inclusion criteria

Outcomes

Primary Outcomes

Not specified

Similar Trials